| Financial Year |
March 31 2023 |
| Monetary Funds |
6,021,681,418.07 |
| Held-for-trading Financial Assets |
1,915,071,623.85 |
| Notes Receivable |
38,983,429.63 |
| Accounts Receivable |
415,658,940.82 |
| Advances to Suppliers |
9,421,399.77 |
| Other Receivables |
36,683,063.92 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,264,051,749.69 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
45,417.11 |
| Other Current Assets |
13,917,300.02 |
| Total Current Assets |
10,181,564,387.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
11,887.52 |
| Long-term Equity Investment |
85,500,686.14 |
| Investment Properties |
68,699,773.21 |
| Fixed Assetes |
1,938,138,598.58 |
| Under-construction Projects |
3,883,136.92 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
18,104,716.55 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
329,084,003.93 |
| R&D expenses |
-- |
| Goodwill |
914,991.98 |
| Long-Term Deferred and Prepaid Expenses |
13,095,387.35 |
| Deferred Income Tax Assets |
273,097,185.36 |
| Other Non-Current Assets |
4,588,057.47 |
| Sub-Total of Non-Current Assets |
2,796,174,056.63 |
| Total Assets |
12,977,738,444.26 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
311,729,809.21 |
| Accounts Received In Advance |
532,257.44 |
| Employee Compensation Payable |
234,906,928.12 |
| Taxes Payable |
183,066,940.17 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
867,208,720.82 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
20,285,295.64 |
| Other Current Liabilities |
15,205,244.52 |
| Sub-Total of Current Liabilities |
2,224,250,034.71 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,628,611.94 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
172,192,647.72 |
| Total Liabilities |
2,396,442,682.43 |
| Paid-In Capital(Or Share Stock) |
654,021,537.00 |
| Capital Surplus |
741,908,843.84 |
| Surplus Reserve |
466,156,871.34 |
| LESS:Treasury Stock |
350,103,264.79 |
| Undistributed Profits |
9,046,687,545.35 |
| Minority Stockholder's Interest |
21,717,040.73 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,559,578,721.10 |
| Owner's Equity（Stockholder's Equity） |
10,581,295,761.83 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,977,738,444.26 |
